Osaka, Japan

Masahiro Takasuga


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiro Takasuga: Innovator in Pharmaceutical Crystallization

Introduction

Masahiro Takasuga is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of crystallization techniques. His innovative work has led to advancements that benefit both research and practical applications in medicine.

Latest Patents

Takasuga holds a patent for "Free base crystals." This invention relates to crystals of (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)-cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one, along with methods for making and using such crystals. This patent showcases his expertise in developing novel compounds that can enhance therapeutic efficacy.

Career Highlights

Takasuga is currently associated with Intra-Cellular Therapies, Inc., where he continues to push the boundaries of innovation in drug development. His work is characterized by a commitment to improving the quality and effectiveness of pharmaceutical products.

Collaborations

Throughout his career, Takasuga has collaborated with notable professionals in the field, including Takashi Abe and Graham Buckton. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Masahiro Takasuga's contributions to the field of pharmaceutical crystallization are noteworthy. His innovative patent and ongoing work at Intra-Cellular Therapies, Inc. highlight his role as a key figure in advancing medical science. His dedication to research and collaboration continues to inspire future innovations in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…